2m 2m 2m 2m 2m 2m 2m
GAIN THERAPEUTIC (GANX)
NASDAQ
$1.04-$0.05 (-4.17%)
Price as of Nov 13, 2026 1:54 PM EST- $47.1MMarket Cap
- -63.88%1-Year Change
- BiotechnologyIndustry
GAIN THERAPEUTIC (GANX)
$1.04-$0.05 (-4.17%)
GANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.08 | ||
Change | -$0.03 (-2.70%) | ||
Open | $1.06 | ||
High | $1.14 | ||
Low | $1.01 | ||
Previous Close | $1.11 | ||
Volume | 300,382 | ||
30-Day Average Volume | 570,836 | ||
1-Week Change | 12.45% | ||
1-Month Change | -31.21% | ||
1-Year Change | -63.88% | ||
3-Year Change | -60.58% | ||
5-Year Change | -86.91% | ||
Fundamentals | |||
Shares Outstanding | 43.6M | ||
Total Assets | $13.2M | ||
Market Cap | $47.1M | ||
Enterprise Value | $35.7M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$3.2M | ||
Free Cash Flow | -$3.0M | ||
EBIT | -$3.1M | ||
EBITDA | -$3.1M | ||
Net Working Capital | $10.3M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 5 | ||
P/E | -15 | ||
PEG | -0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue